Urinary N-acetyl - D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Park, Hayne Cho ^a,b   Hwang, Jin Ho ^a   Kang, Ah Young ^b   Ro, Han ^c   Kim, Myung Gyu ^b   An, Jung Nam ^a   In Park, Ji ^a   Kim, Seung Hyup ^a   Yang, Jaeseok ^b   Oh, Yun Kyu ^a   Oh, Kook Hwan ^a   Noh, Jung Woo ^d   Cheong, Hae Il ^a,b   Hwang, Young Hwan ^a,e   Ahn, Curie ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Gachon University Gil Hospital   (South Korea)

^d Hallym University College of Medicine   (South Korea)

^e Eulji General Hospital   (South Korea)

Author keywords

Autosomal dominant polycystic kidney disease; Biomarkers; Renal function

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; COHORT ANALYSIS; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROSPECTIVE STUDY;

ACETYLGLUCOSAMINIDASE; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84865492308     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-93     Document Type: Article

References (21)

1. Autosomal dominant polycystic kidney disease. Gabow PA, N Engl J Med 1993 329 5 332 342 10.1056/NEJM199307293290508 8321262 (Pubitemid 23210687)
2. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, et al. Kidney Int 2003 64 3 1035 1045 10.1046/j.1523-1755.2003.00185.x 12911554 (Pubitemid 37013840)
3. Biomarkers of acute kidney injury. Vaidya VS, Ferguson MA, Bonventre JV, Annu Rev Pharmacol Toxicol 2008 48 463 493 10.1146/annurev.pharmtox.48.113006. 094615 17937594 (Pubitemid 351738161)
4. Distribution of N-acetyl-beta-D-glucosaminidase isoenzymes along the rabbit nephron. Bourbouze R, Baumann FC, Bonvalet JP, Farman N, Kidney Int 1984 25 4 636 642 10.1038/ki.1984.68 6482167 (Pubitemid 14079958)
5. Characterisation of human N-acetyl-beta-D-glucosaminidase isoenzymes as an indicator of tissue damage in disease. Tucker SM, Pierce RJ, Price RG, Clin Chim Acta 1980 102 1 29 40 10.1016/0009-8981(80)90430-1 7389106 (Pubitemid 10176209)
6. Unified criteria for ultrasonographic diagnosis of ADPKD. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, et al. J Am Soc Nephrol 2009 20 1 205 212 10.1681/ASN.2008050507 18945943
7. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60mL/min/1.73m2. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, et al. Am J Kidney Dis 2010 56 3 486 495 10.1053/j.ajkd.2010.03.026 20557989
8. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. Ann Intern Med 2009 150 9 604 612 19414839
9. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW, Am J Kidney Dis 2002 39 6 1127 1134 10.1053/ajkd.2002.33379 12046022 (Pubitemid 34591926)
10. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Horak E, Hopfer SM, Sunderman FW Jr, Clin Chem 1981 27 7 1180 1185 7237781 (Pubitemid 11071855)
11. The serum levels and urinary excretion of 2 -microglobulin in apparently healthy subjects. Evrin PE, Wibell L, Scand J Clin Lab Invest 1972 29 1 69 74 10.3109/00365517209081057 5014998
12. NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME, J Biol Chem 1997 272 46 29181 29189 10.1074/jbc.272.46.29181 9360996 (Pubitemid 27498209)
13. UK Consensus Conference on Early Chronic Kidney Disease-6 and 7 February 2007. Archibald G, Bartlett W, Brown A, Christie B, Elliott A, Griffith K, Pound S, Rappaport I, Robertson D, Semple Y, et al. Nephrol Dial Transplant 2007 22 9 2455 2457 10.1093/ndt/gfm268 17557775 (Pubitemid 47365506)
14. Urinary N-acetyl-beta-D-glucosaminidase activity in healthy children. Skalova S, Chladek J, Nephrology (Carlton) 2004 9 1 19 21 10.1111/j.1440-1797. 2003.00217.x (Pubitemid 38230526)
15. Angiogenesis in autosomal-dominant polycystic kidney disease. Bello-Reuss E, Holubec K, Rajaraman S, Kidney Int 2001 60 1 37 45 10.1046/j.1523-1755.2001. 00768.x 11422734 (Pubitemid 32587537)
16. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. Doulton TW, Saggar-Malik AK, He FJ, Carney C, Markandu ND, Sagnella GA, MacGregor GA, J Hypertens 2006 24 5 939 945 10.1097/01.hjh.0000222765.30348.0d 16612257 (Pubitemid 43670466)
17. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. Schrier RW, J Am Soc Nephrol 2009 20 9 1888 1893 10.1681/ASN.2008080882 19696226
18. Erythropoietin in polycystic kidneys. Eckardt KU, Mollmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, Scholz H, Keusch G, Buchholz B, Frei U, et al. J Clin Invest 1989 84 4 1160 1166 10.1172/JCI114280 2794053 (Pubitemid 19247586)
19. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Bakker J, Olree M, Kaatee R, de Lange EE, Moons KG, Beutler JJ, Beek FJ, Radiology 1999 211 3 623 628 10352583 (Pubitemid 29249454)
20. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, et al. Am J Kidney Dis 2010 56 5 883 895 10.1053/j.ajkd.2010.06.023 20888104
21. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Parikh CR, Dahl NK, Chapman AB, Bost JE, Edelstein CL, Comer DM, Zeltner R, Tian X, Grantham JJ, Somlo S, Kidney Int 2012 81 8 784 790 10.1038/ki.2011.465 22258321